Home Other Building Blocks 2-Hydroxypyrazine

2-Hydroxypyrazine

CAS No.:
6270-63-9
Catalog Number:
AG003HG1
Molecular Formula:
C4H4N2O
Molecular Weight:
96.0874
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$14
- +
5g
95%
In Stock USA
United States
$57
- +
10g
98%
In Stock USA
United States
$88
- +
25g
98%
In Stock USA
United States
$182
- +
100g
98%
In Stock USA
United States
$557
- +
Product Description
Catalog Number:
AG003HG1
Chemical Name:
2-Hydroxypyrazine
CAS Number:
6270-63-9
Molecular Formula:
C4H4N2O
Molecular Weight:
96.0874
MDL Number:
MFCD00233966
IUPAC Name:
1H-pyrazin-2-one
InChI:
InChI=1S/C4H4N2O/c7-4-3-5-1-2-6-4/h1-3H,(H,6,7)
InChI Key:
HUTNOYOBQPAKIA-UHFFFAOYSA-N
SMILES:
O=c1cncc[nH]1
EC Number:
228-455-2
UNII:
N5VLE8C2MU
NSC Number:
36081
Properties
Complexity:
137  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
96.032g/mol
Formal Charge:
0
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
96.089g/mol
Monoisotopic Mass:
96.032g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
41.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.5  
Literature
Title Journal
Heterologous expression and structural characterisation of a pyrazinone natural product assembly line. Chembiochem : a European journal of chemical biology 20121105
1,3-Diphenyl-4,5-dihydro-1H-pyrazol-5-one. Acta crystallographica. Section E, Structure reports online 20120401
4-[3,4-Dimethyl-1-(4-methyl-phen-yl)-5-oxo-4,5-dihydro-1H-pyrazol-4-yl]-3,4-dimethyl-1-(4-methyl-phen-yl)-4,5-dihydro-1H-pyrazol-5-one. Acta crystallographica. Section E, Structure reports online 20120401
Concise synthesis of an enantiopure bicyclic pyrazinone as constrained peptidomimetic building block. Organic & biomolecular chemistry 20120314
Complexity generation in fungal peptidyl alkaloid biosynthesis: oxidation of fumiquinazoline A to the heptacyclic hemiaminal fumiquinazoline C by the flavoenzyme Af12070 from Aspergillus fumigatus. Biochemistry 20111011
JBIR-56 and JBIR-57, 2(1H)-pyrazinones from a marine sponge-derived Streptomyces sp. SpD081030SC-03. Journal of natural products 20110722
New taxa in Aspergillus section Usti. Studies in mycology 20110630
2-(4-Meth-oxy-benz-yl)-4,6-diphenyl-2,5-diaza-bicyclo-[2.2.2]oct-5-en-3-one. Acta crystallographica. Section E, Structure reports online 20110501
4-[2-(Benzyl-sulfan-yl)acet-yl]-3,4-dihydro-quinoxalin-2(1H)-one. Acta crystallographica. Section E, Structure reports online 20110401
Fungal indole alkaloid biosynthesis: genetic and biochemical investigation of the tryptoquialanine pathway in Penicillium aethiopicum. Journal of the American Chemical Society 20110302
Chiral separation of potent corticotropin-releasing factor-1 receptor antagonists by supercritical fluid chromatography. Journal of pharmaceutical and biomedical analysis 20110220
In situ maleimide bridging of disulfides and a new approach to protein PEGylation. Bioconjugate chemistry 20110216
Structural analysis of prolyl oligopeptidases using molecular docking and dynamics: insights into conformational changes and ligand binding. PloS one 20110101
Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization. Journal of medicinal chemistry 20101111
A family of pyrazinone natural products from a conserved nonribosomal peptide synthetase in Staphylococcus aureus. Chemistry & biology 20100924
Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinones. Bioorganic & medicinal chemistry 20100901
Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors. Bioorganic & medicinal chemistry letters 20100715
Intramolecular 1,6-addition to 2-pyridones. Mechanism and synthetic scope. The Journal of organic chemistry 20100604
Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation. Drug metabolism and disposition: the biological fate of chemicals 20100101
New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regulatory toxicology and pharmacology : RTP 20100101
Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport. BMC cell biology 20100101
4-[(2,5-Dimethyl-anilino)acet-yl]-3,4-di-hydro-quinoxalin-2(1H)-one. Acta crystallographica. Section E, Structure reports online 20091201
[Overview in 45 years of studies on peptide chemistry]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20091001
3-Substituted pyrazinone nucleosides--a new family of D4T analogues. Nucleosides, nucleotides & nucleic acids 20090901
New cyclic somatostatin analogues containing a pyrazinone ring: importance of Tyr for antiproliferative activity. Bioorganic & medicinal chemistry letters 20081201
Synthesis of highly functionalized 2(1H)-pyrazinone 3-carboxamide scaffolds. Organic letters 20081016
Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinase. Journal of enzyme inhibition and medicinal chemistry 20081001
Ethyl-enediammonium bis-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-pyrazol-1-ide): a hydrogen-bond-supported supra-molecular ionic assembly. Acta crystallographica. Section E, Structure reports online 20080901
Sugar-driven prebiotic synthesis of 3,5(6)-dimethylpyrazin-2-one: a possible nucleobase of a primitive replication process. Origins of life and evolution of the biosphere : the journal of the International Society for the Study of the Origin of Life 20080801
Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP). Bioorganic & medicinal chemistry letters 20080801
Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery. The AAPS journal 20080301
3-Benzyl-5-bromo-pyrazin-2(1H)-one. Acta crystallographica. Section E, Structure reports online 20080301
trans-Chlorido[6-chloro-4-(4-methoxy-benz-yl)-3-oxo-3,4-dihydro-pyrazin-2-yl]-bis-(triphenyl-phosphine)palladium(II). Acta crystallographica. Section E, Structure reports online 20080101
Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platform. Bioorganic & medicinal chemistry letters 20071101
Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationships. Medicinal chemistry (Shariqah (United Arab Emirates)) 20071101
Unintentional organophosphate intoxication in children. Pediatric emergency care 20071001
Palladium-catalyzed copper(I)-mediated cross-coupling of arylboronic acids and 2(1H)-pyrazinones facilitated by microwave irradiation with simultaneous cooling. Organic & biomolecular chemistry 20070921
Various Molecular Species of Diacylglycerol Hydroperoxide Activate Human Neutrophils via PKC Activation. Journal of clinical biochemistry and nutrition 20070701
Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV). Current topics in medicinal chemistry 20070101
Transition metal-catalyzed orthogonal solid-phase decoration of the 2(1H)-pyrazinone scaffold using a sulfur linker. Journal of combinatorial chemistry 20070101
Cobalt-mediated [2+2+2] cycloaddition versus C-H and N-H activation of pyridones and pyrazinones with alkynes: an experimental study. Chemistry (Weinheim an der Bergstrasse, Germany) 20070101
Bis and tris indole alkaloids from marine organisms: new leads for drug discovery. Current medicinal chemistry 20070101
Polyphasic taxonomy of Aspergillus section Usti. Studies in mycology 20070101
Synthesis of 3,6-bis[H-Tyr/H-Dmt-NH(CH2)m,n]-2(1H)pyrazinone derivatives: function of alkyl chain length on opioid activity. Bioorganic & medicinal chemistry letters 20061115
Copper(II)-mediated cross-coupling of arylboronic acids and 2(1H)-pyrazinones facilitated by microwave irradiation with simultaneous cooling. Organic letters 20060427
Removal of atrazine, lindane and diazinone from water by organo-zeolites. Water research 20060301
Application of automated mass spectrometry deconvolution and identification software for pesticide analysis in surface waters. Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes 20060101
Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimization. Bioorganic & medicinal chemistry letters 20051015
In vitro metabolism of a thrombin inhibitor and quantitation of metabolically generated cyanide. Journal of pharmaceutical and biomedical analysis 20051004
Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenation. Chemical & pharmaceutical bulletin 20050901
Novel pyrazinone and pyridinone thrombin inhibitors incorporating weakly basic heterobicyclic P(1)-arginine mimetics. European journal of medicinal chemistry 20050801
Synthesis of cyclic endiamino peptides. Journal of the American Chemical Society 20050601
Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity. Journal of medicinal chemistry 20050324
Solid-phase synthesis of the 2(1H)-pyrazinone scaffold: a new approach toward diversely substituted heterocycles. Journal of combinatorial chemistry 20050101
The application of 'click chemistry' for the decoration of 2(1H)-pyrazinone scaffold: generation of templates. Journal of combinatorial chemistry 20050101
N-h insertion reactions of Boc-amino acid amides: solution- and solid-phase synthesis of pyrazinones and pyrazines. Organic letters 20041125
Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation. Bioorganic & medicinal chemistry letters 20041004
Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis. Journal of medicinal chemistry 20040506
Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesia. Journal of medicinal chemistry 20040506
Novel 2',6'-dimethyl-L-tyrosine-containing pyrazinone opioid mimetic mu-agonists with potent antinociceptive activity in mice. The Journal of pharmacology and experimental therapeutics 20040401
Synthesis of 3-aminopyrazinone mediated by 2-pyridylthioimidate-ZnCl2 complexes. Development of an efficient route to a thrombin inhibitor. The Journal of organic chemistry 20031114
Bioactivation of the 3-amino-6-chloropyrazinone ring in a thrombin inhibitor leads to novel dihydro-imidazole and imidazolidine derivatives: structures and mechanism using 13C-labels, mass spectrometry, and NMR. Drug metabolism and disposition: the biological fate of chemicals 20031101
Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors. Journal of medicinal chemistry 20031023
Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex. Journal of medicinal chemistry 20030911
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex. Bioorganic & medicinal chemistry letters 20030721
Non-peptide alphavbeta3 antagonists. Part 6: design and synthesis of alphavbeta3 antagonists containing a pyridone or pyrazinone central scaffold. Bioorganic & medicinal chemistry letters 20030519
Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors. Bioorganic & medicinal chemistry letters 20030310
Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteins. Chemical research in toxicology 20030201
Dmt and opioid peptides: a potent alliance. Biopolymers 20030101
Microwave-enhanced transition metal-catalyzed decoration of 2(1H)-pyrazinone scaffolds. Molecular diversity 20030101
Immunoglobulin E binding determinants on beta-lactam drugs. Current opinion in allergy and clinical immunology 20020801
Pyrazinone conjugates as potential cephalosporin allergens. Bioorganic & medicinal chemistry letters 20010723
Enantioselective synthesis for the (-)-antipode of the pyrazinone marine alkaloid, hamacanthin A. The Journal of organic chemistry 20010713
Imidazo-thiazine, -diazinone and -diazepinone derivatives. Synthesis, structure and benzodiazepine receptor binding. European journal of medicinal chemistry 20010501
Properties